CEVEC NEWS

FREE ONLINE SEMINAR:

ADVANCED TECHNOLOGIES FOR SCALABLE AAV VECTOR PRODUCTION

BY DR. NICOLE FAUST, CEO

Learn about the latest developments in using stable producer cell lines for AAV manufacturing and how the ELEVECTA® system enables a fully scalable and robust vector production process without plasmid transfection or helper viruses.

Cell & Gene Therapy Manufacturing & Commercialization Digital Week – May 3, 2022

KEEP IN TOUCH

Subscribe to receive CEVEC’s latest Press Releases, Conference Information and Webinar Invitations according to our Privacy Policy.

© CEVEC Pharmaceuticals GmbH 2022